1)日本動脈硬化学会(編):動脈硬化性疾患予防ガイドライン2017年版,日本動脈硬化学会,2017
2)メタボリックシンドローム診断基準検討委員会:メタボリックシンドロームの定義と診断基準.日内会誌 94:794-809,2005
3)Sarwar N, Danesh J, Eiriksdottir G, et al:Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115:450-458,2007
4)Okamura T, Kokubo Y, Watanabe M, et al:Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis 209:290-294,2010
5)Kratky D, Obrowsky S, Kolb D, et al:Pleiotropic regulation of mitochondrial function by adipose triglyceride lipase-mediated lipolysis. Biochimie 96:106-112,2014
6)Lass A, Zimmermann R, Oberer M, et al:Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 50:14-27,2011
7)Bertrand T, Augé F, Houtmann J, et al:Structural basis for human monoglyceride lipase inhibition. J Mol Biol 396:663-673,2010
8)日本臨床化学会試薬専門委員会:血清中の中性脂肪濃度測定の勧告法.勧告法総集編2012年版(日本臨床化学会編),日本臨床化学会,pp403-416,2012
9)Carlson LA:Determination of serum triglycerides. J Atheroscler Res 3:334-336,1963
10)Edwards SH, Stribling SL, Pyatt SD, et al:Reference measurement procedure for total glycerides by isotope dilution GC-MS. Clin Chem 58:768-776,2012
11)山本肇,佐竹奏一,二本柳洋志,他:遊離グリセロール未消去による総グリセライド測定の検討 中性脂肪測定国際標準化を見据えた基礎検討.医学検査 65:209-215,2016
12)園田信五,加藤淳子,春日信司:グリセロールを含む脳圧降下剤が酵素を用いた血清中性脂肪測定に及ぼす影響.臨検 27:809-811,1983
13)Nakagawa T, Hirayama S, Watanabe T, et al:Triglyceride concentrations should be measured after elimination of free glycerol to exclude interindividual variations due to adiposity and fasting status. Clin Chem Lab Med 55:e191-e194,2017